Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2596 AL 2610

The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain

Varnum MM, Ikezu T.

Arch Immunol Ther Exp (Warsz). 2012 Aug;60(4):251-66. doi: 10.1007/s00005-012-0181-2. Epub 2012 Jun 19.

Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease

Ikram MK, Cheung CY, Wong TY, Chen CP.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22. doi: 10.1136/jnnp-2011-301628. Epub 2012 Jun 25.

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

Lista S, Faltraco F, Prvulovic D, Hampel H.

Prog Neurobiol. 2013 Feb-Mar;101-102:1-17. doi: 10.1016/j.pneurobio.2012.06.007. Epub 2012 Jun 26.

Gene transfer to skeletal muscle by site-specific delivery of electroporation and ultrasound

Li Y, Wang J, Satterle A, Wu Q, Wang J, Liu F.

Biochem Biophys Res Commun. 2012 Jul 27;424(2):203-7. doi: 10.1016/j.bbrc.2012.06.090. Epub 2012 Jun 26.

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot

Hampel H, Lista S, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):312-36. doi: 10.1016/j.jalz.2012.05.2116.

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

Palmqvist S, Hertze J, Minthon L, Wattmo C, Zetterberg H, Blennow K, Londos E, Hansson O.

PLoS One. 2012;7(6):e38639. doi: 10.1371/journal.pone.0038639. Epub 2012 Jun 22.

The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial

Wharton W, Stein JH, Korcarz C, Sachs J, Olson SR, Zetterberg H, Dowling M, Ye S, Gleason CE, Underbakke G, Jacobson LE, Johnson SC, Sager MA, Asthana S, Carlsson CM.

J Alzheimers Dis. 2012;32(1):147-56. doi: 10.3233/JAD-2012-120763.

Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging

Whitwell JL, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Roberts RO, Boeve BF, Petersen RC, Jack CR Jr; Alzheimer Disease Neuroimaging Initiative.

Arch Neurol. 2012 May;69(5):614-22. doi: 10.1001/archneurol.2011.3029.

Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease

Fehlbaum-Beurdeley P, Sol O, Désiré L, Touchon J, Dantoine T, Vercelletto M, Gabelle A, Jarrige AC, Haddad R, Lemarié JC, Zhou W, Hampel H, Einstein R, Vellas B; EHTAD/002 study group.

J Alzheimers Dis. 2012;32(1):169-81. doi: 10.3233/JAD-2012-120637.

Current insights into the pathophysiology of Alzheimer's disease: selecting targets for early therapeutic intervention

Hampel H.

Int Psychogeriatr. 2012 Aug;24 Suppl 1:S10-7. doi: 10.1017/S1041610212000579.

Visuospatial perception: an emerging biomarker for Alzheimer's disease

Mandal PK, Joshi J, Saharan S.

J Alzheimers Dis. 2012;31 Suppl 3:S117-35. doi: 10.3233/JAD-2012-120901.

[An overview of biomarkers in Alzheimer's disease]

Rong XF, Wang XL.

Yao Xue Xue Bao. 2012 May;47(5):551-7.

Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes

Leuner K, Schulz K, Schütt T, Pantel J, Prvulovic D, Rhein V, Savaskan E, Czech C, Eckert A, Müller WE.

Mol Neurobiol. 2012 Aug;46(1):194-204. doi: 10.1007/s12035-012-8300-y. Epub 2012 Jul 22.

Genome-wide association study of Alzheimer's disease

Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative; Jun G, Baldwin C, Logue MW, Buros J, Farrer L, Pericak-Vance MA, Haines JL, Sweet RA, Ganguli M, Feingold E, Dekosky ST, Lopez OL, Barmada MM.

Transl Psychiatry. 2012 May 15;2(5):e117. doi: 10.1038/tp.2012.45.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias